401
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Polypharmacy, Infectious Diseases, Sexual Behavior, and Psychophysical Health Among Anabolic Steroid-Using Homosexual and Heterosexual Gym Patrons in San Francisco's Castro District

, , , , , , , , & show all

References

  • Antiretroviral Therapy Cohort Collaboration. (2008). Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. The Lancet, 372(9635), 293–299.
  • Bamidele, J. (2014). Gay body dysmorphia. Retrieved from http://www.huffingtonpost.com/jeremy-bamidele/gay-body-dysmorphia_b_5859876.html
  • Barucco, R. (2014). The muscular elephant in the room: Gay men and steroid use. Retrieved from http://www.huffingtonpost.com/renato-barucco/the-muscular-elephant-in-_b_5692126.html
  • Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012). Global epidemiology of HIV infection in men who have sex with men. The Lancet, 380(9839), 367–377.
  • Blashill, A. J., & Safren, S. A. (2014). Sexual orientation and anabolic-androgenic steroids in US adolescent boys. Pediatrics, 133(3), 469–475.
  • Bolding, G., Sherr, L., & Elford, J. (2002). Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction, 97(2), 195–203.
  • Bolding, G., Sherr, L., Maguire, M., & Elford, J. (1999). HIV risk behaviours among gay men who use anabolic steroids. Addiction, 94(12), 1829–1835.
  • Centers for Disease Control and Prevention. (2010a). Hepatitis B—general information. Retrieved from http://www.cdc.gov/hepatitis/HBV/PDFs/HepBGeneralFactSheet.pdf
  • Centers for Disease Control and Prevention. (2010b). Hepatitis C–general information. Retrieved from http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet.pdf
  • Centers for Disease Control and Prevention. (2013). HIV among gay and bisexual men. Retrieved from http://www.cdc.gov/hiv/pdf/risk_gender_238900B_HIV_Gay_Bisexual_MSM_FS_final.pdf
  • Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: A clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf
  • Centers for Disease Control and Prevention. (2015). HIV among gay and bisexual men. Retrieved from http://www.cdc.gov/hiv/pdf/HIV-MSM-english-508.pdf
  • Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: Demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 4(1), 1.
  • Dillon, P., Copeland, J., & Peters, R. (1999). Exploring the relationship between male homo/bi-sexuality, body image and steroid use. Culture, Health & Sexuality, 1(4), 317–327.
  • Dodge, T., & Hoagland, M. F. (2011). The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Drug and Alcohol Dependence,114(2), 100–109.
  • Gates, G. J. (2006). Same-sex couples and the gay, lesbian, bisexual population: New estimates from the American Community Survey. Retrieved from http://williamsinstitute.law.ucla.edu/wp-content/uploads/Gates-Same-Sex-Couples-GLB-Pop-ACS-Oct-2006.pdf
  • Grov, C., & Parsons, J. T. (2006). Bug chasing and gift giving: The potential for HIV transmission among barebackers on the internet. AIDS Education and Prevention,18(6), 490–503.
  • Hope, V. D., McVeigh, J., Marongiu, A., Evans-Brown, M., Smith, J., Kimergård, A., … Ncube, F. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study. BMJ Open, 3(9), e003207.
  • Ip, E. J., Barnett, M. J., Tenerowicz, M. J., Kim, J. A., Wei, H., & Perry, P. J. (2010). Women and anabolic steroids: An analysis of a dozen users. Clinical Journal of Sport Medicine, 20(6), 475–481.
  • Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The Anabolic 500 survey: Characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, 31(8), 757–766.
  • Ip, E. J., Lu, D. H., Barnett, M. J., Tenerowicz, M. J., Vo, J. C., & Perry, P. J. (2012). Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy, 32(10), 910–919.
  • Ip, E. J., Yadao, M. A., Shah, B. M., & Lau, B. (2016). Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users. AIDS Care, 28(3), 294–299.
  • Kanayama, G., & Pope, H. G., Jr. (2011). Gods, men, and muscle dysmorphia. Harvard Review of Psychiatry, 19(2), 95–98.
  • Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13.
  • Larance, B., Degenhardt, L., Degenhardt, L., Copeland, J., & Dillon, P. (2008). Injecting risk behaviour and related harm among men who use performance-and image-enhancing drugs. Drug and Alcohol Review, 27(6), 679–686.
  • Lelutiu-Weinberger, C., Pachankis, J. E., Golub, S. A., Ja'Nina, J. W., Bamonte, A. J., & Parsons, J. T. (2013). Age cohort differences in the effects of gay-related stigma, anxiety and identification with the gay community on sexual risk and substance use. AIDS and Behavior, 17(1), 340–349.
  • Liu, A. Y., Vittinghoff, E., Chillag, K., Mayer, K., Thompson, M., Grohskopf, L., … Collins, B. (2013). Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. Journal of Acquired Immune Deficiency Syndromes, 64(1), 87.
  • Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., … Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PloS One, 8(12), e81997.
  • Mays, V. M., & Cochran, S. D. (2001). Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. American Journal of Public Health, 91(11), 1869–1876.
  • McNeil, D. G. (2013). Rise in unprotected sex by gay men spurs H.I.V. fears. The New York Times. Retrieved from http://www.nytimes.com/2013/11/28/health/unprotected-sex-among-gay-men-on-the-rise-health-officials-say.html?
  • Midgley, S. J., Heather, N., Best, D., Henderson, D., McCarthy, S., & Davies, J. B. (2000). Risk behaviours for HIV and hepatitis infection among anabolic-androgenic steroid users. AIDS Care, 12(2), 163–170.
  • Miller, K. E., Hoffman, J. H., Barnes, G. M., Sabo, D., Melnick, M. J., & Farrell, M. P. (2005). Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Substance Use & Misuse, 40(11), 1637–1657.
  • Morbidity and Mortality Weekly Report. (2010). Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008. Retrieved from https://www.cdc.gov/mmwr/pdf/wk/mm5937.pdf
  • Moskowitz, D. A., & Roloff, M. E. (2007). The existence of a bug chasing subculture. Culture, Health & Sexuality, 9(4), 347–357.
  • Nwanyanwu, O. C., Chu, S. Y., Green, T. A., Buehler, J. W., & Berkelman, R. L. (1993). Acquired Immunodeficiency Syndrome in the United States associated with injecting drug use, 1981–1991. The American Journal of Drug and Alcohol Abuse, 19(4), 399–408.
  • O'Cleirigh, C., & Safren, S. (2007). Breaking the mold or business as usual? Meeting the challenges of HIV prevention in people with serious mental illness and substance use disorders. Clinical Psychology: Science and Practice, 14(1), 34–38.
  • O'Cleirigh, C., Traeger, L., Mayer, K. H., Magidson, J. F., & Safren, S. A. (2013). Anxiety specific pathways to HIV sexual transmission risk behavior among young gay and bisexual men. Journal of Gay & Lesbian Mental Health, 17(3), 314–326.
  • Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: a survey of 500 users. Medicine & Science in Sports & Exercise, 38(4), 644–651.
  • Pope, H. G., Jr., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. The American Journal on Addictions, 23(4), 371–377.
  • Pope, H. G., Jr., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: An Endocrine Society scientific statement. Endocrine Reviews,35(3), 341–375.
  • Sagoe, D., Huang, K., Molde, H., Andreassen, C. S., & Pallesen, S. (2016). Perceived anabolic–androgenic steroid use is associated with perceived neuroticism. Journal of Substance Use, 21(3), 263–267.
  • Sagoe, D., McVeigh, J., Bjørnebekk, A., Essilfie, M. S., Andreassen, C. S., & Pallesen, S. (2015). Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis. Substance Abuse Treatment, Prevention, and Policy, 10, 12.
  • Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398.
  • Strathdee, S. A., & Stockman, J. K. (2010). Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Current HIV/AIDS Reports, 7(2), 99–106.
  • Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings (HHS Publication No. (SMA) 14-4863). Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.htm#3.1.1
  • Vorspan, F., Mehtelli, W., Dupuy, G., Bloch, V., & Lépine, J. P. (2015). Anxiety and substance use disorders: co-occurrence and clinical issues. Current Psychiatry Reports, 17(2), 1–7.
  • Yu, J., Hildebrandt, T., & Lanzieri, N. (2015). Healthcare professionals' stigmatization of men with anabolic androgenic steroid use and eating disorders. Body Image, 15, 49–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.